A detailed history of Advisor Net Financial, Inc transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 200 shares of KPTI stock, worth $168. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$168
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$0.72 - $1.66 $360 - $830
-500 Reduced 71.43%
200 $0
Q4 2021

Jan 19, 2022

SELL
$5.21 - $8.61 $521 - $861
-100 Reduced 12.5%
700 $5,000
Q1 2021

Apr 14, 2021

BUY
$9.85 - $17.69 $1,970 - $3,538
200 Added 33.33%
800 $8,000
Q2 2020

Aug 26, 2020

BUY
$16.6 - $25.25 $1,660 - $2,525
100 Added 20.0%
600 $11,000
Q1 2020

May 14, 2020

BUY
$14.38 - $27.72 $7,190 - $13,860
500 New
500 $10,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $67M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.